Page last updated: 2024-11-03

ro 31-8220 and Carcinoma, Thymic

ro 31-8220 has been researched along with Carcinoma, Thymic in 1 studies

Ro 31-8220: a protein kinase C inhibitor

Research Excerpts

ExcerptRelevanceReference
" Here we have examined the effects of two PKC inhibitors, staurosporine and the more selective agent Ro 31-8220, on IL1 responses in the murine thymoma line EL4."7.69Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1alpha in EL4 thymoma cells. ( Mahon, TM; Matthews, JS; O'Neill, LA, 1997)
" Here we have examined the effects of two PKC inhibitors, staurosporine and the more selective agent Ro 31-8220, on IL1 responses in the murine thymoma line EL4."3.69Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1alpha in EL4 thymoma cells. ( Mahon, TM; Matthews, JS; O'Neill, LA, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahon, TM1
Matthews, JS1
O'Neill, LA1

Other Studies

1 other study available for ro 31-8220 and Carcinoma, Thymic

ArticleYear
Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1alpha in EL4 thymoma cells.
    The Biochemical journal, 1997, Jul-01, Volume: 325 ( Pt 1)

    Topics: Animals; Cell Membrane; Cytosol; Drug Synergism; Enzyme Inhibitors; Indoles; Interleukin-1; Interleu

1997